Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals to Lay Off 36 Staffers as Part of Restructuring

NEW YORK, July 18 (GenomeWeb News) - Serologicals will lay off 23 positions in its Lake Placid, NY, business and offer relocation options to 39 additional employees, GenomeWeb News has learned.


The job cuts, which also include 13 staffers in the company's Temecula, Calif., facility, is part of Serologicals' efforts to cut costs in its research segment by $3 million to $3.5 million a year. Employees offered relocation would mainly work in Serologicals' Chemicon International business, located in Temecula.


As GenomeWeb News reported last week, the Atlanta-based company said it will integrate several functions of its Upstate and Chemicon units through the remainder of the year, including business segment management, R&D/business development, marketing, technical support, scientific sourcing, intellectual property/licensing, and finance and accounting.


Serologicals said it expects to incur between $2 million and $3 million in one-time costs related to severance payments, retention payments, and relocation costs that it will record in the third quarter.


Serologicals, which has more than 1,000 employees worldwide, operates three companies: Chemicon International, based in Temecula; Upstate Group, based in Charlottesville, Va.; and Celliance, based in Atlanta.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.